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A main approach given to cancer treatment is a therapeutic regimen that combines 
35
Indoximod has been trial in mono and combined therapy to treat sarcoma, NSCLC, 36 melanoma and colorectal cancer (Yentz S and Smith D, 2018) . Although the initial focus 37 on 1-MT took into account its property to inhibit IDO, currently it is clear that many of 
Statistics
40
The statistical significance of differences in the mean values of all experimental 41 groups was calculated using a ONE Way ANOVA. P values < 0.05 were considered to 42 be statistically significant. M and the addition of 1-MT enantiomers did not caused changes in this concentration 8 ( Figure 1A ).
10
To evaluate the effect of 1-MT on cytokine production, we measured cytokines in observed for D-1-MT while no effect at all was observed for the L-enantiomer.
24
We also use the same conditions of co-cultures as above to access the cross talking Moreno AC, Clara RO, Coimbra JB, Júlio AR, Albuquerque RC, Oliveira EM, et al. 
